So, when FDA finally recognized 15223-1 in whole earlier this year, it was a reason to celebrate in that we could use the symbols without adjacent text. This seemed like a no-brainer, so I didn't attend any webinars on the topic. However, a colleague has called to my attention that FDA requires the use of TEXT on the package label to point to the location of the glossary. Really? I suppose this isn't a big deal for devices only sold in the US or only English speaking countries, but doesn't that defeat the whole purpose of using symbols AND defeat the purpose of symbols referring to the IFU?
I know that the 510(k)s in my world do NOT include this ridiculous statement and are going through RTA and SR just fine.
What's your take on this? Have you updated your box labels to include this statement? Is there a chance that FDA will see the problem and fix it in the foreseeable future?
As an RA professional I want to be compliant, but I can't shake the feeling that updating all of our labelling just to add this statement isn't warranted and could be rolled in with other changes in the future.
Looking forward to your comments!
Tina
------------------------------
Tina O'Brien RAC, MS
Director of Regulatory Affairs
Aroa Biosurgery
Auckland
New Zealand
------------------------------